标题
E2F7−EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-20
DOI
10.1038/s41416-020-01032-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma
- (2020) Rui Yang et al. ONCOGENE
- Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
- (2019) Anthony D. Saleh et al. CLINICAL CANCER RESEARCH
- TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis
- (2019) Guanghui Zhang et al. BRITISH JOURNAL OF CANCER
- The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
- (2018) Lu Gan et al. Journal of Hematology & Oncology
- SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma
- (2018) Rui Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer
- (2018) Shanshan Xiang et al. ONCOGENE
- MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis
- (2018) Yu-Shui Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway
- (2017) Yang Nan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type
- (2017) Yemin Wang et al. JOURNAL OF PATHOLOGY
- EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL
- (2017) Dorothy Brach et al. MOLECULAR CANCER THERAPEUTICS
- KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth
- (2017) M Riverso et al. ONCOGENE
- PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3
- (2017) Jorge A. Benitez et al. Nature Communications
- Linkage of E2F1 transcriptional network and cell proliferation with respiratory chain activity in breast cancer cells
- (2016) Kazunori Mori et al. CANCER SCIENCE
- Feedback regulation between atypical E2Fs and APC/CCdh1coordinates cell cycle progression
- (2016) Michiel Boekhout et al. EMBO REPORTS
- Tigecycline Inhibits Glioma Growth by Regulating miRNA-199b-5p-HES1-AKT Pathway
- (2016) R. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy
- (2016) Masaru Katoh Epigenomics
- Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations
- (2015) E. Riquelme et al. CANCER RESEARCH
- PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer
- (2015) Nisha Nagarsheth et al. CANCER RESEARCH
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation
- (2015) Rui Yang et al. Oncotarget
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
- (2013) Neha Tiwari et al. CANCER CELL
- Mapping Human Epigenomes
- (2013) Chloe M. Rivera et al. CELL
- Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-κB Pathway in Adult T Cell Leukemia and Other Cancers
- (2012) Makoto Yamagishi et al. CANCER CELL
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- Integration and analysis of genome-scale data from gliomas
- (2011) Gregory Riddick et al. Nature Reviews Neurology
- Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis
- (2011) Bum-Kyu Lee et al. NUCLEIC ACIDS RESEARCH
- MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
- (2011) S Fujii et al. ONCOGENE
- E2F7 Can Regulate Proliferation, Differentiation, and Apoptotic Responses in Human Keratinocytes: Implications for Cutaneous Squamous Cell Carcinoma Formation
- (2009) L. Endo-Munoz et al. CANCER RESEARCH
- E2f1–3 switch from activators in progenitor cells to repressors in differentiating cells
- (2009) Jean-Leon Chong et al. NATURE
- Atypical E2Fs: new players in the E2F transcription factor family
- (2009) Tim Lammens et al. TRENDS IN CELL BIOLOGY
- Repression of E-cadherin by the polycomb group protein EZH2 in cancer
- (2008) Q Cao et al. ONCOGENE
- Atypical E2F activity restrains APC/CCCS52A2 function obligatory for endocycle onset
- (2008) T. Lammens et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search